Safety and Immunogenicity of Live Attenuated Influenza H5N2
NCT01841918
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Influenza Due to Influenza A Virus Subtype H5N2
Interventions
BIOLOGICAL:
Avian Flu Vaccine
Sponsor
Mahidol University
Collaborators
[object Object]
[object Object]